A Review of Adapalene in the Treatment of Acne Vulgaris
Received 7 January 2008; accepted 9 June 2008.
Abstract
Topical retinoids help address the early lesions of acne vulgaris. Consensus guidelines advocate the use of topical retinoids as the primary treatment for most forms of acne vulgaris. However, all topical retinoid preparations may be irritating, and this may contribute to underutilization in clinical practices. Topical adapalene fosters topical retinoid treatment of acne with less irritation. Adapalene is a more stable molecule than tretinoin. Adapalene can be used without concern for photo-deactivation. Because of its chemical stability, adapalene can be used in combination with benzoyl peroxide products. The availability of a stable topical retinoid associated with little irritation may facilitate meeting acne treatment consensus guidelines.
aDepartment of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine; Winston-Salem, North Carolina
bDepartment of Public Health Sciences, Center for Dermatology Research, Wake Forest University School of Medicine; Winston-Salem, North Carolina
cDepartment of Pathology, Center for Dermatology Research, Wake Forest University School of Medicine; Winston-Salem, North Carolina
Address correspondence to: Steven R. Feldman, M.D., Ph.D., Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071
Potential conflicts of interest: Dr. Feldman has received research, speaking and/or consulting support from several manufacturers of topical retinoids including Galderma, OrthoNeutrogena, and Stiefel. The Center for Dermatology Research is supported by an educational grant from Galderma Laboratories, L.P. Dr. Yentzer and Ms. Irby have no conflicts to disclose.